PreprintAll rights reservedbioRxiv
Structure-Based Drug Design of Novel Inhibitors Targeting the Thiamine Biosynthesis Pathway in Bacteria
- 1SASTRA Deemed University
Related
- The health-promoting functions of γ-aminobutyric acid (GABA) and lactic acid bacteria metabolism: From biosynthesis to applications in the food industry
- Sugarcane bZIP16 regulates internode elongation by targeting gibberellic acid biosynthesis pathway
- Engineering Stapled Peptide Inhibitors Reveals Design Principles for Targeting Talin-Induced Integrin Activation
- Rational Design of Diaryl Ether-Based Dual Inhibitors Targeting Successive Essential Enzymes HadAB and InhA in Mycobacterium tuberculosis
- Targeting Skin Hyperpigmentation with Nature-Derived Tyrosinase Inhibitors: Sources, Mechanisms, and Translational Challenges
BibTeX
@misc{krishna2026structurebased,
title = {{Structure-Based Drug Design of Novel Inhibitors Targeting the Thiamine Biosynthesis Pathway in Bacteria}},
author = {N. Krishna and V. Ulaganathan},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.05.756923},
url = {https://www.biorxiv.org/content/10.64898/2026.10.05.756923v1},
}
RIS
TY - UNPB
TI - Structure-Based Drug Design of Novel Inhibitors Targeting the Thiamine Biosynthesis Pathway in Bacteria
AU - N. Krishna
AU - V. Ulaganathan
PY - 2026
DA - 2026/10/05
PB - bioRxiv
DO - 10.64898/2026.10.05.756923
UR - https://www.biorxiv.org/content/10.64898/2026.10.05.756923v1
ER -